Conversely, in HR-negative BC, the release of pro-inflammatory factors (e.g., IL-6 and TNF-α) from subcutaneous fat in an obese environment significantly enhances the invasive potential of BC cells and increases chemotherapy resistance (58). Here, IL6 is linked to breast cancer.